Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Cumberland Pharmaceuticals Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −2 vs. Q1 2025
- Shares held
- 3.68M
- −598.7K (−14.0%) vs. Q1 2025
- Total value
- $12.3M
- −$5.82M (−32.0%) vs. Q1 2025
- New holders
- 6
- 9 more added
- Sold out
- 8
- 10 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CPIX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $16.0M |
| Q1 2026 | 29 | $8.97M |
| Q4 2025 | 27 | $11.8M |
| Q3 2025 | 30 | $10.6M |
| Q2 2025 | 31 | $12.3M |
| Q1 2025 | 33 | $18.1M |
| Q4 2024 | 20 | $4.36M |
| Q3 2024 | 22 | $2.61M |
| Q2 2024 | 23 | $3.18M |
| Q1 2024 | 23 | $3.63M |
| Q4 2023 | 25 | $3.89M |
| Q3 2023 | 21 | $4.17M |
| Q2 2023 | 23 | $3.52M |
| Q1 2023 | 21 | $4.77M |
| Q4 2022 | 23 | $5.61M |
| Q3 2022 | 17 | $5.89M |
| Q2 2022 | 22 | $5.62M |
| Q1 2022 | 26 | $8.17M |
| Q4 2021 | 26 | $13.2M |
| Q3 2021 | 23 | $7.43M |
| Q2 2021 | 28 | $8.36M |
| Q1 2021 | 31 | $9.77M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Cumberland Pharmaceuticals Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Huntington National Bank | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 2 | $7 | 0.00% | +2 | New |
| Bank of America Corp | 94 | $315 | 0.00% | +26+38.2% | Added |
| Capital Advisors, Ltd. LLC | 437 | $1.00K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 1,428 | $4.78K | 0.00% | +1,428 | New |
| Tower Research Capital LLC (TRC) | 2,102 | $7.04K | 0.00% | +2,102 | New |
| Group One Trading, L.P. | 8,222 | $27.5K | 0.00% | +8,222 | New |
| UBS Group AG | 8,818 | $29.5K | 0.00% | +3,481+65.2% | Added |
| XTX Topco Ltd | 10,280 | $34.4K | 0.00% | +10,280 | New |
| Wiley Bros.-Aintree Capital, LLC | 11,000 | $36.9K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 11,527 | $38.6K | 0.00% | −17,412−60.2% | Reduced |
| Morgan Stanley | 12,398 | $41.5K | 0.00% | +9,738+366.1% | Added |
| Simplex Trading, LLC | 14,218 | $47.0K | 0.00% | −4,882−25.6% | Reduced |
| Cresset Asset Management, LLC | 18,475 | $61.9K | 0.00% | −1,500−7.5% | Reduced |
| Northern Trust Corp | 19,603 | $65.7K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 32,265 | $108.1K | 0.00% | +9,510+41.8% | Added |
| Heron Bay Capital Management | 33,251 | $111.4K | 0.02% | +33,251 | New |
| State Street Corp | 33,700 | $112.9K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 44,288 | $148.0K | 0.00% | −4,849−9.9% | Reduced |
| BlackRock, Inc. | 51,168 | $171.4K | 0.00% | +18,510+56.7% | Added |
| Bank of New York Mellon Corp | 72,513 | $242.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 74,406 | $249.3K | 0.00% | +48,592+188.2% | Added |
| Geode Capital Management, LLC | 100,237 | $335.8K | 0.00% | +1,146+1.2% | Added |
| Boothbay Fund Management, LLC | 180,229 | $603.8K | 0.02% | −43,569−19.5% | Reduced |
| Bridgeway Capital Management, LLC | 188,355 | $631.0K | 0.01% | +4,200+2.3% | Added |
| J. Goldman & Co LP | 220,707 | $739.4K | 0.02% | −20,774−8.6% | Reduced |
| Dimensional Fund Advisors LP | 252,889 | $847.2K | 0.00% | +700+0.3% | Added |
| Vanguard Group Inc | 411,786 | $1.38M | 0.00% | −4,783−1.1% | Reduced |
| Renaissance Technologies LLC | 494,963 | $1.66M | 0.00% | −8,400−1.7% | Reduced |
| Ikarian Capital, LLC | 595,932 | $2.00M | 0.66% | −144,068−19.5% | Reduced |
| Millennium Management LLC | 775,976 | $2.60M | 0.00% | −33,921−4.2% | Reduced |
| Berkshire Asset Management LLC | 0 | $0 | 0.00% | −153,810−100.0% | Sold out |
| Adage Capital Partners GP, L.L.C. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −71,776−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −70,419−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −19−100.0% | Sold out |